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ABSTRACT
Historically, once a cell became infected, it was consid-
ered to be beyond all help. By this stage, the invading
pathogen had breached the innate defenses and was be-
yond the reach of the humoral arm of the adaptive im-
mune response. The pathogen could still be removed by
cell-mediated immunity (e.g., by NK cells or cytotoxic T
lymphocytes), but these mechanisms necessitated the
destruction of the infected cell. However, in recent years,
it has become increasingly clear that many cells possess
sensor and effector mechanisms for dealing with intra-
cellular pathogens. Most of these mechanisms are not
restricted to professional immune cells nor do they all ne-
cessitate the destruction of the host. In this review, we
examine the strategies that cells use to detect and de-
stroy pathogens once the cell membrane has been pene-
trated. J. Leukoc. Biol. 96: 233–244; 2014.
Introduction
For many years, immune recognition was attributed solely to
professional cells, circulating guardians that detect patho-
gens through extracellular receptors, such as the BCRs and
TCRs. This assumption formed the basis of the clonal-selec-
tion theory [1], in which lymphocytes had randomly pro-
duced antigen receptors that were selected on the basis of
their ability to lead to enough activation to allow clonal ex-
pansion should the cognate antigen appear but not overac-
tivation, which would lead to the deletion of the cell in neg-
ative selection. Whereas this theory was able to explain is-
sues of immune memory and tolerance, it was unable to
describe fully the requirement for two signals in immune
activation [2]. It was at this stage in our understanding two
decades ago that Charles A. Janeway, Jr., described a new
theory [3], in which there were two arms of the immune
recognition: an adaptive arm that comprised the clonally
selected lymphocytes and an innate arm that used germline-
encoded receptors to sense conserved molecular patterns.
These defensive strategies cooperate to ensure that a rapid
and correct response is formed to any intruders. Much work
has followed since then [4, 5], with the identification of
many of these receptors, which suggested that it is not only
the leukocytes that can detect pathogens, but also, cells that
are not part of professional immunity have a limited capa-
bility to sense infection. To follow Janeway’s description of
the development of immunology, the latest evolution in the
pattern recognition theory is that extracellular identification
is not the only method of sensing, but there is also intracel-
lular detection of pathogens, forming the basis of the first
half of this review. However, sensing of infection is useless
unless the organism attempts to rectify the problem, and we
focus on these effector mechanisms in the remainder of this
review article. If professional immune cells were not the
only cell types that could detect pathogens, then it might be
expected that these professional immune cells were also not
the only method to remove the pathogen. In addition to
the recruitment of cytotoxic T cells, NK cells, neutrophils,
macrophages, and other leukocytes, which are well-reviewed
elsewhere [6 – 8], recent evidence suggests that to some
level, infected cells themselves are able to eliminate intra-
cellular pathogens in a new paradigm, called cell-autono-
mous immunity [9]. Since the discovery of IFN as an inhibi-
tory factor produced by cells that lead to the establishment
of an antiviral state over one-half of a century ago [10], it
has been shown that individual cells have the ability to re-
strict pathogens by themselves. However, only recently has
this “black box” of inhibitory activity been explained with
some possible mechanisms by which cells react to intracellu-
lar microbes.
This review does not attempt to be an exhaustive guide
on all of the intracellular factors that a pathogen may en-
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counter but provides an overview of concepts and classes of
sensors and effector mechanisms, with an emphasis on anti-
viral immunity.
INTRACELLULAR PATHOGEN DETECTION
The pattern recognition theory required the identification of
germline-encoded receptors (PRRs), which can detect pathogens
that have entered the cells, along with the substances that are
naturally identified by the cell for immune activation without the
education of a selection process. The substances to be detected
must be highly conserved and can be derived from self-molecules
that are normally hidden from the PRRs by compartmentaliza-
tion, becoming exposed during infection or cellular damage
(DAMPs), or from the pathogens themselves (PAMPs) and could
take the form of nucleic acids, pathogen surface constituents
(e.g., LPS), or other small molecules [11]. These PRRs would
have to differentiate among pathogen, danger, and host, not just
by the presence of the molecule itself but by its location and/or
modifications. It was one decade after publication of Janeway’s
initial theory that the evidence for some of these receptors sur-
faced. An overview of these receptors is shown in Fig. 1.
TLRs
Famously, the TLRs were the first of the PRRs to be discovered
[12, 13], with over 10 described, and are well-reviewed else-
where [7, 14]. TLRs are largely restricted to professional im-
mune cells [15], such as plasmacytoid DCs, although some
TLRs, e.g., TLR4, are expressed on nonprofessional cells.
TLR1, -2, -4, and -6 recognize lipids (such as TLR4-sensing
LPS), TLR5 recognizes flagellin, whereas TLR3 senses dsRNA;
TLR7 and -8 detect ssRNA, and TLR9 recognizes dsDNA [16].
In addition, humans have TLR10 [17], although the ligand for
this is yet to be determined, with mice also possessing TLR11
[18], TLR12 [19] against Toxoplasma gondii profilin, and
TLR13 recognizes viral [20] and bacterial ribosomal RNA
[21]. As a result, TLR1, -2, -3, -5, and -6 predominantly sense
bacteria, whereas TLR3, -7, -8, -9, and -13 can sense bacterial,
viral, or protozoan nucleic material. However, TLRs are found
on the plasma membrane or in endosomes [14], suggesting
that they may be more important in the detection of patho-
gens that have not yet entered into the cell cytosol, either ex-
tracellular or on an incoming path of infection [22].
TLRs consist of a TM protein that contains extracytosolic,
LRR domains to bind their respective ligands; TLR3, -7, -8,
and -9 bind to nucleic acids, with the remainder binding other
DAMPs or PAMPs, such as the surface components of bacteria.
Activation of these TLRs leads to dimerization, revealing their
TIR domain for the use of adaptors MyD88 or TRIF, setting
off intracellular transduction cascades, leading to the phos-
phorylation of transcription factors.
NLRs
The other large class of PRRs are the NLRs, and the details are
beyond the scope of this review but are well-described elsewhere
[23–25]. Like the TLRs, the NLRs use LRRs to form binding do-
mains but are present intracellularly. Based on homology, 20 of
these have been discovered in humans and seem to be able to
detect a variety of different insults, from bacterial glycans and
lipid moieties to self-molecules, such as ATP or monosodium
urate, to chemical irritants, e.g., silica, asbestos. Most PAMP li-
gands have yet to be linked to their respective NLRs, although
NOD1 and -2 have been found to be stimulated by bacterial pep-
tidoglycans, and NLRP3 responds to RNA and pore-forming tox-
ins [26]. Most possess a CARD domain on the N-terminus for
protein–protein interactions, with others having PYDs for recruit-
ment of ASC, which contains a CARD domain for the down-
stream function. Depending on this N-terminal domain, these
NLRs have different functions, which can range from activation
of transcription factors, activation of the inflammasome, or mod-
ulation of MHC class II presentation.
Nucleic acid receptors
From these large groups of PRRs, there are also the intracellular,
cytosolic nucleic acid sensors. The RNA sensors are the best-de-
scribed out of this group, although much interest has occurred
recently with the discovery of several novel DNA sensors. In the-
ory, for nondividing eukaryotic cells, with well-defined nuclei to
contain DNA, detection of cytosolic DNA should be relatively sim-
ple, whereas the RNA sensors require the detection of certain
motifs that expose the sequence as being of nonhost origin.
RIG-I (also known as DDX58) is a dsRNA helicase that is the
most-studied in the family of RLRs [27], which also contain
MDA5 and LGP2/DHX58. These possess DEAD or DEXH
(where X can be any amino acid) containing helicase domains
for dsRNA recognition and a RD, with RIG-I and MDA5 also hav-
ing CARD domains to lead to the activation of MAVS. RIG-I and
MDA5 rely on different properties of the dsRNA strands for de-
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tection; RIG-I detects the 5= triphosphate in a manner that is con-
sistent with that found in pan-handle dsRNA [28], as well as be-
ing activated with a much shorter dsRNA sequence than MDA5
[29]. LGP2 is believed to detect to similar sequences as RIG-I,
even having a higher affinity for binding to dsRNA sequences
[30], but as a result of the lack of the CARD domain, it is be-
lieved to function as a positive regulator of RNA-induced antiviral
immunity [31]. Upon binding of these helicases to RNA, confor-
mation changes are induced that lead to the displacement of the
RD, such that the helicase can multimerize and bind to MAVS on
the mitochondrial surface [30, 32].
PKR is the most well-studied member of the eIF2-specific
kinase subfamily [33, 34]. PKR is able to detect long stretches
of dsRNA, with a preference for hairpin loops, followed by a
ssRNA sequence [35]. It can also be activated by heparin or
the stress-induced protein activator of the IFN-induced protein
kinase [36]. These ligands are detected via a dsRNA-binding
domain, allowing dimerization and autophosphorylation. PKR
is then able to feed into several downstream pathways, such as
phosphorylation of the transcription factors, p53, IRF, AP-1,
and NF-B [33], as well as the direct modification of factors
involved in translation, such as eIF2 [34].
Other RNA sensors, such as the OAS family of receptors, are
also present in the cell as 10 isoforms [37, 38], although are only
weakly induced by IFN in human cells [39]. These bind to
dsRNA, recognizing the sugar backbone, and lead to the synthe-
sis of atypical 2=-5= chains of adenosine from ATP, mainly form-
ing 5=-triphosphorylated triadenylate or tetradenylate [38, 40, 41].
This acts as a second messenger, leading to the activation of a
specific partner, RNase L, which is discussed later in this review.
No other binding partner could be found in mice with RNase L
knocked out [42], so it is likely that RNase L is the only pathway
that is activated by the OAS family. As a second messenger is re-
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Figure 1. Localization and classification of intracellular sensors. Intracellular pathogen sensors can be classified according to their mechanism of
recognition, be it via PAMPs and DAMPs, RNA, DNA, or other features of a pathogen-replication cycle. Most of these sensors are soluble, cytoplas-
mic proteins. TLR, NLR, and galectin-8 sensing of burst endosomes detect danger associated with infection. RNA is detected by RLRs, PKR, OAS,
DDX1 and -21, and DHX36. DNA is sensed by transcription by RNA Pol III to RNA products, ALRs, DAI, cGAS, DNA PK, MRE11, DDX41 and -60,
and DHX9 and -36. Other proteins—LSm14A, LRRFIP1, and the HMGB family—have been found to be important in the detection of both types
of nucleic acids. Other detection methods for pathogens, based on their replication cycle, are present. Mx GTPases and TRIM5 sense the virus
capsid coat, with TRIM21 detecting antibody carried into the cytosol on incoming pathogens. Tetherin is able to sense budding events from the
plasma membrane. NALP3, NLR family, PYD-containing 3.
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is removed when no longer necessary. As genomic DNA strands
are 3=-5=, usual phosphodiesterases would be predicted not to be
able to function on these unique 2=-5= linkage chains. This was
found to be the case, with an IFN-inducible enzyme that rapidly
degraded the 2=-5= oligoadenylate strands [43] and much later
identified as a 2= phosphodiesterase [44], found to be responsi-
ble for signal dampening.
DNA sensors in the cell have been reviewed well else-
where [45– 47], with a few noticeable examples provided
here. Unterholzner [47] also provides an interesting discus-
sion on the probable reasons as to why so many DNA sen-
sors have been proposed.
RNA sensors can also be used in the detection of DNA
viruses—through the properties of RNA Pol III. Cytosolic
DNA, if A:T-rich, leads to the recruitment of RNA Pol III,
which functions by transcribing this sequence into RNA [48].
This phenomenon has been demonstrated for adenovirus [49]
and for intracellular bacteria, such as Legionella [48]. The
resultant RNA can then be detected by the RNA sensors de-
scribed previously, in particular, RIG-I [48, 50].
DAI was the first cytosolic receptor to be discovered that
sensed DNA directly [51]. Subsequent work has identified the
role of DAI in initiating transcription factor activation, such as
that of the IRF and NF-B families [51–53]. The full role of
DAI in the immune response is unknown, however, as mice
lacking DAI have normal responses to infection [54], and de-
pletion in human cells has no effect on IFN production [55].
DAI may have a role at a certain time of infection or possibly
in a cell type-specific manner.
Paralogues IFI16 and AIM2 are both HIN200-containing
proteins with additional PYDs in a family called the ALRs [56–
58]. IFI16 appears to have a greater affinity to ssDNA than ds-
DNA [59], although it is believed that both are able to signal
in response to dsDNA in the cytosol by detection of the sugar-
phosphate backbone [60]. As they contain PYDs, they have
features similar to those of the NLRs, signaling through the
protein ASC in the inflammasome, leading to the oligomeriza-
tion of STING through CARD–CARD interactions between
STING and ASC. Recently, IFI16 has been implicated in posi-
tive and negative roles during HIV infection, both in the de-
tection of the virus [61], as well as leading to the death of the
quiescent, nonproductively infected CD4 T cells [62].
Much interest has been placed in the recently identified
cGAS as a receptor for cytosolic DNA [63]. Like the other
DNA sensors, it appears to bind dsDNA by the backbone, al-
though cGAS interacts with DNA through two binding sites
[64], leading to activation of the enzyme. The bound form is
similar to the structure of the OAS family members when
bound to dsRNA [65], and activation also leads to the produc-
tion of the second messenger, cGAMP. Interestingly, cGAMP is
arranged in a cyclical fashion, whereas GMP is attached in an
atypical 2=-5= manner, and the adenosine is in the usual 3=-5=
linkage [66]. This second messenger is then detected by
STING, before activation of immune pathways. Bacteria pro-
duce a form of cGAMP that is 3=-5=-linked in both directions,
which has a slightly different affinity for STING but is able to
elicit similar immune pathways [67]. The cGAS–STING path-
way has been shown to be important in the detection of ade-
novirus [68] and HIV [69], with the recruitment of specific
host factors (cleavage and polyadenylation specificity factor
subunit 6 and cyclophilins, Nup358 and CypA) leading to im-
mune evasion from cGAS [70]. Currently, unlike the OAS fam-
ily and the 2=-phosphodiesterase [44], no enzyme involved in
the breakdown of cGAMP has been reported, although it is
almost certain that it must exist. It is possible that the 2=-phos-
phodiesterase may also possess activity over cGAMP, as a result
of the presence of the atypical 2=-5= linkage.
In addition, recently, the DNA damage response has been
linked with sensing DNA in the cytosol, with sensors MRE11
[71] and DNA PK [72] described to possess roles in this pro-
cess. All of these are believed to feed into immune pathways
through the activation of STING, which appears to be central
to the recognition of DNA [73].
Other RNA and DNA sensors in the cytosol may be present.
It was discovered that other DEAD and DEXH helicases, such
as DHX9 and DHX36, are able to sense DNA in plasmacytoid
DCs [74], with DDX41 found to signal through STING [75]
and DDX60 leading to antiviral signaling [76].
Some of these sensors have been found to be able to detect
DNA and RNA. For example, LSm14A, a protein in processing
bodies that matures RNA, has been found to initiate responses
to viral RNA and DNA [77], although requiring the assistance
of RIG-I, MDA5, or STING. LRRFIP1 is a cytosolic protein that
has been found to bind to DNA and RNA [78] and mediates
the production of cytokines in a manner independent of usual
immune transcription factors, such as NF-B or IRFs, instead,
functioning through the actions of -catenin. Finally, the
HMGB, which when released by dying cells acts as a DAMP by
binding to TLRs and other receptors [79], have been found to
perform similar functions in the cytosol, where they are nor-
mally present—able to bind RNA and DNA (although HMGB2
binds only DNA) [80]. HMGB proteins appear to assist in the
detection of these nucleic acid immunogens by improving pre-
sentation to other PRRs. Whether these promiscuous sensors
are receptors in their own right or chaperones to sort out par-
ticular types of nucleic acid for other receptors to detect is still
unknown, but further research may demonstrate that there are
more nucleic acids sensors still to be found.
The understanding of the nature of the detection may provide
clues to the unchanging features of these nucleic acids, useful for
improving vaccine formulation. In addition, the understanding of
the different mechanisms of nucleic acid sensing demonstrates
the requirement for complementary detection of these different
features and evolutionary-produced functional redundancy to
circumvent pathogen antagonism.
Other pathogen receptors
Following from these relatively well-characterized groups of
pathogen sensors are other newly described sensors, capable of
detecting pathogens, independent of their nucleic acids.
The Mx GTPase family of proteins are dynamin-like, INF-
inducible sensors [81], showing activity for viruses, such as in-
fluenza, hepatitis B virus, Thogoto virus, and HIV. The mecha-
nism is not fully understood, although Mx GTPases are be-
lieved to be able to sense nucleocapsid structures for viruses,
with a direct interaction described for the Thogoto virus [82].
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How this interaction takes place is not fully understood, as it is
not virus-specific, even with viruses from vastly different fami-
lies—ortho-Mxs, lentiviruses, bunyaviruses, picornaviruses, and
hepadnaviruses all thought to be able to be sensed by this
mechanism. A lattice of Mx proteins is believed to be formed
around the nucleocapsid by activation, with the outcome of
sensing appearing to be a direct block to infection, which will
be discussed later in this review.
Another nucelocapsid sensor, specific to lentiviruses, is
TRIM5. This member of the TRIM-containing family has a
RING, B-box, coiled-coils, and PRYSPRY domains. The RING
and B-box are important in producing polyubiquitin chains for
the targeted neutralization of the virus and the activation of
transduction cascades for transcription factor activation, with
the PRYSPRY domain important for detection of nucleocapsid.
As with the Mx GTPases, a lattice is believed to be formed
around the offending nucleocapsid before its destruction, with
many interactions via the PRYSPRY domain required for bind-
ing [83]. In addition, binding appears to be necessary for the
restriction of lentiviruses, but as PRYSPRY mutants exist, which
bind equally well to the capsid but have no restriction func-
tion, it suggests that other factors may be required [84].
Whereas the Mx GTPases and TRIM5 interact directly with
lentiviral capsids, another indirect, but potentially more versa-
tile, method of recognizing the surface of the pathogen has
been described. Recently, antibodies were demonstrated to be
able to be carried into the cytosol when bound to nonenvel-
oped viruses and bacteria. These intracellular, pathogen-
bound antibodies are sensed by the cytosolic antibody receptor
TRIM21 [85–90]. This is a detection of pathogen surfaces in
the cytosol, via the previous attachment of antibody as an in-
termediate. This antibody-dependent intracellular immunity
has the added advantage of using an intermediate that can
adapt to pathogen evolution (especially viruses, given the
rapid rate of evolution), while having a defined, conserved
binding site for TRIM21 to detect [87, 91]. However, this pro-
cess is highly dependent on the pathogen carrying antibody
into the cytosol, so any virus or bacteria that changes its sur-
face as it enters the cell will probably shed this layer of detec-
tion (e.g., enveloped viruses). Like its paralogue TRIM5,
TRIM21 function appears to be dependent on the ability to
form polyubiquitin chains. The discovery of the function of
TRIM21 as a sensor for intracellular antibody opens up further
questions (antibody was always thought to only function in the
extracellular spaces, with its presence in the cytosol a flag for a
breach in the membrane integrity of the cell), such as: could
other serum proteins also function in a similar manner?
In addition to sensors that detect the surface of the pathogen,
further intracellular sensors for infection have been described.
Recently, endosomal fusion was found to be detected by cells in a
STING-dependent manner [92] but unlike the previous descrip-
tion of the function of STING, was independent of nucleic acids
or viral capsid. The actual mechanism of this detection, including
the sensor itself, is still currently unknown, but it suggests that
the cell might be able to sense small changes to its barrier integ-
rity before there is the spilling of the classically described DAMPs
of ATP and cellular forms of glucose [11].
For many pathogens, endosomal escape is required to move
from the extracellular space to the cytosol. Recently, galectin 8
was found to act as a PRR for complex glycans that are present
on the outer membrane leaflet of the plasma membrane [93].
Breakdown of the endosome integrity leads to the activation of
autophagy via the ubiquitin-mediated activation of the adaptor
molecule NDP52, and NDP52 activation on ubiquitin-coated
Salmonella typhimurium enterica enterica has been described as
leading to the recruitment of TBK1, via adaptors Nap1 and
Sintbad (similar to Nap1 TBK1 adaptor) [94], suggesting that
galectin 8 detection of cytosolically exposed surface glycans
may also lead to immune activation.
In addition, intracellular detection of LPS, independent of
its classical receptor TLR4, has been described in macrophages
[95]. Whereas unstimulated Tlr4/ mice were resistant to
LPS challenge, Tlr4/mice primed with poly(I:C) were as
susceptible to LPS-mediated sepsis as wild-type mice, suggest-
ing that there was an additional pathway for detection of this
endotoxin up-regulated by poly(I:C) stimulation. As with the
fusion detection, the sensor and the signaling mechanisms are
currently unknown.
Evidence suggests that innate immune activation in cells de-
pends on at least two signals [2]; it is likely that all of these sen-
sors function together to alert of a microbial presence. Having
several layers of receptors, each of which is detecting a different
aspect of the pathogen, enables not only a safety feature to pre-
vent accidental activation of the immune system but also provides
a method of recognizing the type of pathogen that is present and
hence, modulating the subsequent immune response accordingly.
Whereas the sensors may have a different mechanism for
detection, they all fit with Janeway’s original idea: a conserved
pattern is detected by the cell, leading to immune activation.
In the case of TLRs and RLRs, the pattern can be DAMPs or
PAMPs, detected through germline-encoded, LRR domains.
Some of the nucleic acid sensors detect particular motifs, such
as pan-handle RNA, hairpin loops, and A:T rich regions,
whereas the capsid sensors seem to detect the repeating sub-
units of the viral nucleocapsid. TRIM21 detects pathogens via
the repeated pattern on the antibody intermediate. The detec-
tion of burst endosomes, through the recognition of the expo-
sure of complex glycans during endosomal rupture by galectin
8, is based on the detection of host ligands used as a danger
signal to possible damage by a pathogen. Together, these pat-
terns are present in the “lifestyle” of the pathogens, properties
that are difficult for them to avoid completely.
Cross-species analysis of these receptors allows an evolutionary
viewpoint of how these methods of detection arrived. The pro-
duction of molecular scaffolds with domains with easily modifi-
able regions attached to activation domains is the repeated
method of generating receptors (Fig. 2). TLRs have LRRs modi-
fied for binding their respective ligands [14], which are also
found on the intracellular NLRs, albeit with a different activatory
domain [24]. TLRs signal via the adaptor molecule MyD88,
which contains a DD motif, whereas the NLRs use the evolution-
arily similar CARD domain for their activated interactions, which
is also shared by the RLRs [32], as well as the adaptor molecules
for the ALRs [57]. Interestingly, fish NLRs possess PRYSPRY do-
mains, which are traditionally associated with butyrophilins or the
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TRIM family [96]. Together, these modular assemblies suggest
that the evolutionary process of creating these diverse receptors is
through duplication and fusion of genes to create a new family of
receptors, followed by selection for variants that are better at
binding to PAMPs or DAMPs. This process is best exemplified by
TRIMCyp, a lentiviral-restriction factor found in owl monkeys
[97] and macaques [98], which is believed to have evolved inde-
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CARD CARD Helicase Domain RD
Figure 2. Domain architecture of intracellular sensors. PRRs of the TLR, NLR, RLR, ALR, and TRIM families possess similar binding and signaling
domains, suggesting that activation leads to similar innate programs of responses against pathogens. Note that the death fold is conserved in
CARD, DD, and PYDs, with PYDs related to the PRYSPRY domains. NACHT, Nucleotide-binding and CARD.
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binding properties of CypA (an interaction required by the virus
for evasion from TRIM5) [99] and nucleic acid detection [70],
with the activatory domains of TRIM5. This has provided these
monkeys with strong resistance to infection by HIV-1 [97]. In es-
sence, the simplicity of these sensors enables the greater ability of
these genes to recombine into a useful receptor by attaching a
binding domain of a protein to an action domain in a modular
manner, should a selection pressure arise. Changing the activa-
tory domain on the sensor can lead to a different response, based
on the location of the receptor; for example, DNA-binding TLRs
lead to transcription factor activation, whereas similarly binding
NLRs would also lead to activation of the inflammasome and ap-
optosis—an important difference, as TLRs may pick up extracel-
lular DNA, whereas cytosolic DNA is a sure sign that a patho-
genic process is present. This versatility of the innate immune
system to make use of several component domains and combine
them to form functional receptors has led to the variety of differ-
ent sensors that are present.
The discovery of sensors for endosomal lysis, endosomal fu-
sion, a novel intracellular LPS receptor, as well as the detec-
tion of cytosolic serum proteins shows that much more work is
left to be carried out on these intracellular receptors and even
suggests that further sensors may still be discovered.
INDUCTION OF AN ANTIMICROBIAL
STATE
In response to the detection of the pathogen, the cell is able
to make it more difficult for the organism to persist. The pro-
duction of “antimicrobial states”, which make it more difficult
for the pathogen to take control, has mostly been studied in
the context of IFN stimulation, from its initial discovery as an
inhibitory factor [10] to use as an antiviral drug [100, 101].
These studies all suggested that individual cells were either
capable of preventing themselves from being infected or were
able to limit the spread of the infection. Current work has
been involved in finding and characterizing the mechanisms
by which pathogens are restricted by these cellular changes.
It was thought for a long time that the only way to target an
intracellular pathogen would be by destruction of the cell by
cytotoxic cells, such as NK cells [102, 103] and T cells [104],
or by monocyte/macrophage phagocytosis of infected cells
[105, 106]. In addition, cell death by apoptosis [107] or pyrop-
tosis [108, 109] after caspase induction is a well-known re-
sponse to infection. However, in the context of this review, we
will focus on more recently discovered noncytotoxic methods
of dealing with a pathogen in the cell.
Whole pathogen destruction
The cytoplasm contains both “generic” and “pathogen-specific”
mechanisms for pathogen destruction. Perhaps the best-stud-
ied pathogen-specific machinery is involved in the TRIM5
restriction of retroviruses that occurs in the primates. Human
TRIM5 is capable of restricting equine infectious anemia vi-
rus (a lentivirus) and N-MLV (a -retrovirus) but not HIV-1.
However, TRIM5 from certain species of Old World mon-
keys, such as the African green monkey and Tantalus monkey,
are capable of restricting HIV-1 but not the equivalent primate
lentivirus, SIV [110]. The observation that a virus must over-
come TRIM5-mediated virus restriction to establish infection
reflects the potency of this strategy for denying the invading
pathogen passage across the cytoplasm.
Despite differences in viral recognition among primate spe-
cies, the effector mechanism of virus restriction appears to be
conserved. During cell entry, retroviruses shed their envelope,
and the viral capsid becomes exposed to the cytoplasm. Dur-
ing the normal course of infection, a carefully orchestrated
and inter-related series of events must occur before the inte-
gration of the viral DNA into the host genome: reverse tran-
scription, capsid uncoating, and (in the case of lentiviruses)
nuclear entry. Whereas the mechanism of action of TRIM5 is
not known conclusively, it is known that TRIM5 interferes
with these processes. Studies with proteasome inhibitors have
suggested that TRIM5 has two distinct mechanisms. Firstly,
physical interaction of TRIM5 with the capsid protein results
in a lattice of TRIM5 forming around the viral core [111],
which interferes with the normal passage of the virus across
the cytoplasm into the nucleus, whereas secondly, TRIM5-
meditated ubiquitination targets the virus for destruction by
the proteasome [112].
Whereas TRIM5 represents a restriction factor dedicated to
protection against retroviruses, TRIM21 provides defense
against a broader range of invaders. Any event, be it infection
or damage, that results in the presence of antibodies in the
cytoplasm will activate TRIM21. In the case of invading, anti-
body-coated viruses, TRIM21, like TRIM5, provides a potent,
early postentry block to infection by using its E3 ubiquitin-li-
gase activity to target the incoming virions for proteasomal
degradation [86]. Interestingly, the antibody-coated virus rep-
resents a challenging substrate for the proteasome and re-
quires prior disassembly by the AAA ATPase p97/VCP (an en-
zyme with segregase and unfoldase activity) [85]. Whether
TRIM5 also requires the activity of p97/VCP is unknown.
In addition to the TRIM E3 ligase-mediated degradation of
the virus, the proteasome is involved in the direct destruction
of pathogens from other sensors.
The Mx GTPases form around the viral capsid [113] and
interfere with the transport of viruses to their sites of replica-
tion, such as the Golgi compartment or the nucleus, possibly
by preventing host-cofactor recruitment. Viral capsids have
been found by microscopy to be located in a perinuclear loca-
tion, suggesting that their infectious cycle has been stalled.
This implies that at some stage, the cell would dispose of these
potentially infectious virions. Mx GTPases have been found to
colocalize in promyelocytic leukemia protein bodies with
SUMO-1 and SUMO-1-activating enzyme [114], providing a
mechanism for proteasomal degradation of viral components.
Aside from proteasomal destruction, whole pathogens can
also be cleared from the cell by autophagy, which is a cata-
bolic process, in which the cell encloses substances to be de-
graded within an isolation membrane, which later fuses with a
lysosome. Macroautophagy is the main pathway to be investi-
gated and involves the degradation of large organelles or pro-
tein complexes in the cytosol [115]. The isolation membrane
is produced when the mammalian target of rapamycin com-
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plex is inhibited, leading to the activation of the ULK1 com-
plex (ULK1, ATG13, ATG17), along with ATG12 and LC3 pro-
teins. Autophagy has been discovered to play important roles
in immunity [116]. Detection of the pathogen was thought to
be a result of engagement with cell-surface receptors, such as
TLRs, or ubiquitination of the pathogen components them-
selves [116], but recently, it was discovered that broken endo-
somes can be sensed by galectin-8, activating autophagy
through the adaptor NDP52 [93]. This phenomenon was dem-
onstrated for Salmonella infection and sterile damage. In addi-
tion to Salmonella, autophagy has been shown to be important
in the defense against Mycobacterium tuberculosis [117] and has
been demonstrated to be antagonized by picornaviruses [118].
Interestingly, influenza infection requires autophagy for repli-
cation [119]. In addition to the direct destruction of viruses,
autophagy is thought to improve antigen presentation.
Genome destruction
The cytosol possesses resting nuclease activity. IFN is known to
create a state that leads to the increased degradation of long
nucleotide sequences in the cytosol. This leads to efficient re-
moval of the genetic material of the pathogen that has en-
tered the cell. In addition, aside from the destruction of the
nucleic acid polymers themselves, a loss of the integrity of the
genetic code can be created, such that the produced pathogen
is no longer viable.
One of the best described of these methods is the RNase L
pathway [37]. The strands of 2=-5= chains of adenosine produced
by OAS lead to the activation of RNase L, binding via ankyrin
repeats, causing dimerization of RNase L and enabling its nu-
clease activity. This nuclease activity particularly favors uracil-rich
regions, preferentially cleaving after UU or UA sequences [120].
Both host and viral RNA are cleaved in this process, but whereas
the host is able to transcribe mRNA from chromosomal DNA, an
RNA virus would be destroyed in this process [38]. The nuclease
activity is able to create the stretches of RNA that are detected by
other PRRs, especially those of the RLR family [121]. A combina-
tion of the two roles allows RNase L to have antiviral and antibac-
terial roles [122, 123].
Whereas RNase L is involved in genome destruction, the
APOBEC family of proteins is capable of compromising the
integrity of the pathogen’s genetic code through the deamina-
tion of cytosine to uracil [124]. This activity is usually used for
processes, such as somatic hypermutation, gene conversion,
and class-switch recombination. However, it was discovered
that APOBEC3G is able to lead to immunity against retrovi-
ruses [124, 125]. APOBEC3G and APOBEC3F are packaged
into produced virions by a process that is not understood
[126], later acting to mutate the genome of these viruses after
infection. This hypermutation does not occur on the viral
RNA but only occurs after reverse transcription and occurs in
the negative sense strand of the DNA [127], registering as
guanosine-to-adenine transitions in the positive sense strand.
These mutations would lead to recognition via DNA damage-
response proteins or create nonviable genomes. In addition,
APOBEC3G was able to cause interruption with the processing
of the long-terminal repeat regions, disrupting integration into
the host genome [127]. Along with this defect, an interruption
to reverse transcription has been found, involving the aberrant
processing of the primer tRNA [128], suggesting that the
APOBEC family may have other functions in addition to sim-
ply editing and hypermutating [129].
Nutritional immunity
In addition to removing the pathogen directly, another method
in which to restrict the persistence of infection is to prevent repli-
cation. One mechanism by which this takes place is by limiting
the number of nutrients that the pathogen requires.
Whereas the cytosol is used as a store for many nutrients in
cells, most of these are not free to be used by the pathogen.
For instance, glucose is phosphorylated quickly when inside of
the cell to prevent its egress from the cell [130], as well as any
additional diffusion through bacterial membranes. In addition,
it is increasingly being demonstrated that bacteria rely on cal-
cium gradients for signaling [131]. In the resting cytosol, the
concentration of calcium is 95 nM [132]. A bacterium would
have to possess proteins of incredibly high affinity to produce
these gradients when the cytosolic concentration is already so
low. Iron availability is also poor intracellularly, as it is in the
wrong redox state (3 as opposed to 2) for binding to bac-
terial proteins [133]. Intracellular bacteria have to find meth-
ods of being able to use the ferric protein-bound iron, and
indeed, professional intracellular dwellers have been identified
to modulate how the host cells handle iron [134].
In fact, the redox state of the intracellular space provides
incredible difficulty for nonspecialized organisms. Bacteria
carry out respiration at their periplasmic membrane, requiring
the production of proton or sodium ion gradients across this
lipid bilayer. However, the cytosol is already more acidic (pH
7.0 vs. 7.4) [130] and has a much lower sodium concentration
(12 mM vs. 145 mM) [130], making the maintenance of these
gradients difficult. In Escherichia coli and Propionigenium modes-
tum [135], membrane potentials in the order of 100 mV are
required for production of ATP. Eukaryotic organelles, which
are adapted to these conditions, are at their maximal produc-
tion of ATP with gradients of 50 mV. Prokaryotes in these
same gradients are at only 15% of their maximal rate of ATP
synthesis.
In addition, it has long been known that cells become quies-
cent when treated with IFN, arrested at the G1 stage of the cell
cycle, with the mechanisms well-reviewed elsewhere [136]. This
stall in the cell cycle limits nutrients, such as nucleotides, for
viral replication, as the synthesis of such raw materials occurs
predominantly in S-phase of cell division. The best studied of
these is thymidine synthesis. Deoxythymidine is required to be
phosphorylated to be used by replication machinery, a process
carried out by thymidine kinase 1 in the cytosol [137]. This
enzyme is under very specific timing regulation, only being
expressed preceding replication [138] and rapidly degraded
after [139]. Prevention of cells entering cell division limits the
quantity of raw materials available for viral replication. In addi-
tion, the chromosomes will still be packaged in the nucleus,
hence, enabling easier discrimination between self and incom-
ing nucleic acids.
Similar to this method of nucleotide limitation, SAMHD1 is
an IFN-induced restriction factor that has been found to pos-
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sess triphosphohydrolase activity [140], converting the nucleo-
side triphosphate back into the nucleoside, as well as possible
nuclease activity [141]. Together with tight transcriptional con-
trol over the phosphorylation enzymes, these enzymatic abili-
ties allow SAMHD1 to restrict herpes simplex virus 1 [142]
and HIV [143] by limiting the available dNTP pool.
Infected cells can also inhibit invading pathogens at the level
of protein production. In addition to its role in sensing dsRNA,
PKR is able to lead to stalling of ribosomes, so that protein syn-
thesis is halted [33, 34]. Phosphorylation of eIF2 causes a se-
questration of the guanine nucleotide exchange factor eIF2,
preventing the exchange of GDP for GTP on eIF2, so that the
ribosome preinitiation complex cannot be reformed [34]. This
prevention of the recycling of ribosomes causes a decrease in to-
tal protein synthesis, which in the context of infection, is aimed
at limiting the number of viral progeny produced [144]. This
translational control appears to be somewhat selective, not only
sparing the production of IFN but also being required for in-
creased induction of this cytokine [145].
Pathogen egress prevention
If the pathogen cannot be cleared by the aforementioned
mechanisms, in addition to signaling, the cell has another
method to limit the spread of infection. If the cell makes the
pathogen unable to leave, then the pathogen will not be able
to infect a neighboring cell. This act of “cell altruism” (given
that the cell has already been infected and the virus repli-
cated) has been found to be the property of an IFN-inducible
plasma membrane protein, tetherin [146], which is a disulfide-
linked homodimer with a TM domain at the N-terminus and a
GPI anchor at the C-terminus. When a virus attempts to bud
from the infected cell, tetherin ties the virus to the cell by
these two domains. This method of virus restriction has been
found to be active against HIV-1 [146], dengue virus [147],
Ebola virus [148], and Sendai virus [149]. It appears that bud-
ding HIV-1 virions have a preference for incorporating the
GPI anchor into their envelopes over the TM domain [150],
suggesting that this enables tetherin to engage in other func-
tions, such as initiating immune signaling [151]. Notably,
many methods of viral antagonism to this restriction mecha-
nism have been found, such as Vpu for HIV-1 [146] and Sen-
dai virus hemagglutinin–neuraminidase and fusion proteins
[149], which target tetherin for ubiquitination and subsequent
degradation, whereas Ebola virus glycoprotein disrupts teth-
erin homodimer formation [148].
Paracrine signaling
With all of these cell-autonomous mechanisms for removing a
pathogen, it is worth noting that cells in a multicellular organ-
ism do not function alone. Even attachment to basement
membranes, neighboring cells, and collagen leads to constant
signaling about the nature of the cell. One of the main activi-
ties of the transcriptional changes in the cell is to lead to the
production of cytokines, which can initiate some of these in-
hibitory effectors in neighboring cells before infection (e.g.,
IFN), act as a chemotactic attractant for professional cells
(e.g., CCL4), or can lead to the production of acute-phase
proteins (e.g., IL-6). The functions of these secreted proteins
are beyond the scope of this review but are well-described else-
where [7, 10, 152, 153]. Notably, most of the methods that act
to remove the pathogen directly also lead to some level of sig-
naling. For example, TRIM5 [154] and TRIM21 [88, 90] sig-
nal via the production of lysine-63-linked ubiquitin chains,
APOBECs and RNase L can lead to sensing of viral nucleic
acids from their edited products [37, 121, 129], and tetherin
leads to transcription factor activation [151].
Increasing evidence has amassed that cells are capable of deal-
ing with infections themselves in cell-autonomous immunity.
Many of these features are highly conserved, with phylogeny stud-
ies demonstrating that the basic strategies are evolutionarily an-
cient [155] but with hallmarks of selection to counter different
pathogens, as in the Red Queen hypothesis. In fact, the general
principles are clear demonstrations of convergent evolution, such
as the nucleic acid destruction of RNase L and APOBECs when
compared with the bacterial endonuclease-restriction enzyme-
defense system against bacteriophages [156].
Knowledge of the ability of single cells to deal with infection
provides us with interesting insight into how the immune sys-
tem functions as a whole. When a cell is infected by a patho-
gen, the cell is not merely a hijacked bystander but can sense
infection, alerting other cells (neighboring cells as well as pro-
fessional immune cells), as well as dealing with the pathogen
by limiting its spread. The possible speed of these systems
when compared with classical adaptive immunity is particularly
beneficial, given the rate at which pathogens can replicate and
the importance for the host organism to limit this replication
for survival.
CONCLUDING REMARKS
The observation that much of intracellular immunity has been
described only relatively recently may, in fact, reflect what a
successful defensive strategy it is. In humans, many potential
pathogens (e.g., N-MLV) that may be targeted consistently by
intracellular immune mechanisms do not commonly cause dis-
ease for this very reason. Those pathogens that are able to in-
fect cells and result in disease must necessarily subvert these
systems to establish infection. Further understanding of intra-
cellular immunity will lead to increased understanding of
mechanisms of pathogenesis and inform the development of
antimicrobial therapeutics aimed at revealing the pathogen to
the immune system.
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